Antigen binding proteins specific for serum amyloid P component

Details for Australian Patent Application No. 2011223048 (hide)

Owner Glaxo Group Limited

Inventors Bhinder, Tejinder Kaur; Ford, Susannah Karen; Germaschewski, Volker; Lewis, Alan Peter; Pepys, Mark Brian

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011223048

PCT Pub. Number WO2011/107480

Priority 61/309,957 03.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

4 October 2012 PCT application entered the National Phase

  PCT publication WO2011/107480 Priority application(s): WO2011/107480

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223049-Method of diagnostic of inflammatory bowel diseases

2011223044-Method for recycling sheet material coated with a release agent and uses of the thus recycled material